Colorectal cancer: From prevention to personalized medicine

doi:10.3748/wjg.v20.i22.6786

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 22

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (19180)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-7) series.

Item

Count

PDF

1683

WORD

499

HTML

14364

Figures (1-1)

239

Tables (1-7)

270

Sum=17055

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1112

Download

1013

Sum=2125

Jun 14, 2014 (publication date) through Nov 27, 2024

Times Cited of This Article

Times Cited (266)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Jun 14, 2014; 20(22): 6786-6808
Published online Jun 14, 2014. doi: 10.3748/wjg.v20.i22.6786

Colorectal cancer: From prevention to personalized medicine

Gemma Binefa, Francisco Rodríguez-Moranta, Àlex Teule, Manuel Medina-Hayas

Gemma Binefa, Cancer Prevention and Control Program, Catalan Institute of Oncology, IDIBELL, CIBERESP, Hospitalet de Llobregat, 08908 Barcelona, Spain

Gemma Binefa, Department of Clinical Sciences, University of Barcelona, Hospitalet de Llobregat, 08908 Barcelona, Spain

Francisco Rodríguez-Moranta, Endoscopy Unit, University Hospital of Bellvitge, IDIBELL, CIBERESP, Hospitalet de Llobregat, 08908 Barcelona, Spain

Àlex Teule, Genetic Counseling Unit, Catalan Institute of Oncology, Hospitalet de Llobregat, 08908 Barcelona, Spain

Manuel Medina-Hayas, Department of Morphological Sciences, Universitat Autonoma de Barcelona, Bellaterra, 08193 Barcelona, Spain

Author contributions: All of the authors contributed in each phase of the paper (design, acquisition and interpretation of data); all authors revised the draft of the manuscript and approved the final version.

Supported by Partially funded by the Carlos III Health Institute No. PI11/01593

Correspondence to: Gemma Binefa, MD, MPH, Cancer Prevention and Control Program, Catalan Institute of Oncology, IDIBELL, CIBERESP, Hospitalet de Llobregat, Av. Gran Via 199-203, 08908 Barcelona, Spain. gbinefa@iconcologia.net

Telephone: +34-93-2607351 Fax: +34-93-2607956

Received: September 28, 2013
Revised: January 16, 2014
Accepted: March 6, 2014
Published online: June 14, 2014
Processing time: 261 Days and 15.4 Hours

Core Tip

Core tip: Although there are different strategies for screening, the number of which is increasing due to the potential of emerging technologies in molecular marker application, not all strategies meet the criteria required for screening tests in population programs; the three most accepted tests are fecal occult blood test, colonoscopy and sigmoidoscopy.